NCT01642147

Brief Summary

Few studies look into cerebral blood flow (CBF) changes during emergence from general anesthesia for craniotomy. The purpose of this study is to demonstrate CBF changes during emergence from general anesthesia for craniotomy, through monitoring blood oxygen saturation of jugular vein bulb and transcranial Doppler.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2012

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 17, 2012

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2012

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
4 months until next milestone

Results Posted

Study results publicly available

April 23, 2013

Completed
Last Updated

June 24, 2013

Status Verified

May 1, 2013

Enrollment Period

2 months

First QC Date

July 8, 2012

Results QC Date

March 9, 2013

Last Update Submit

May 15, 2013

Conditions

Keywords

Cerebral blood flowTranscranial DopplerEmergence from general anesthesia

Outcome Measures

Primary Outcomes (12)

  • Mean Blood Flow Velocity in Middle Cerebral Artery

    It was the baseline mean blood flow velocity in middle cerebral artery.

    before general anesthesia

  • Mean Blood Flow Velocity in Middle Cerebral Artery

    after surgery at extubation (average surgery duration: craniotomy group 214min, abdominal group 207min)

  • Mean Blood Flow Velocity in Middle Cerebral Artery

    30min after extubation

  • Mean Blood Flow Velocity in Middle Cerebral Artery

    60min after extubation

  • Mean Blood Flow Velocity in Middle Cerebral Artery

    90min after extubation

  • Mean Blood Flow Velocity in Middle Cerebral Artery

    120min after extubation

  • Oxygen Saturation of Jugular Venous Bulb

    before general anesthesia

  • Oxygen Saturation of Jugular Venous Bulb

    at extubation

  • Oxygen Saturation of Jugular Venous Bulb

    30min after extubation

  • Oxygen Saturation of Jugular Venous Bulb

    60min after extubation

  • Oxygen Saturation of Jugular Venous Bulb

    90min after extubation

  • Oxygen Saturation of Jugular Venous Bulb

    120min after extubation

Study Arms (2)

Patients undergoing craniotomy

EXPERIMENTAL

Patients undergoing craniotomy who are scheduled for selective supratentorial tumor removal surgery will be randomly chosen and recruited. Transcranial Doppler (TCD) measures,jugular venous bulb catheterization, radial artery catheterization, and tumor removal surgery under general anesthesia will be performed.

Device: Transcranial Doppler (TCD)Procedure: jugular venous bulb catheterizationProcedure: Tumor removal surgery under general anesthesiaProcedure: Radial artery catheterization

Patients undergoing abdominal surgery

ACTIVE COMPARATOR

Randomly chosen patients undergoing selective abdominal surgery. Transcranial Doppler (TCD) measures,radial artery catheterization, and major abdominal surgery under general anesthesia will be performed.

Device: Transcranial Doppler (TCD)Procedure: Radial artery catheterizationProcedure: Abdominal surgery under general anesthesia

Interventions

A 2-MHz Transcranial Doppler probe (MULTI-DOP P2.2C; DWL, Elektronische Systeme GmbH, Germany) will be used to measure both sides of Vmca of both patients undergoing craniotomy and patients undergoing abdominal surgery. The signal will be range-gated to a depth of 45 to 60 mm at temporal bone window to achieve the optimal signal according to standard techniques. The measures will be recorded in the operation room before anesthesia, in the recovery room at extubation, 30, 60, 90, and 120 min after extubation.

Also known as: TCD
Patients undergoing abdominal surgeryPatients undergoing craniotomy

After local anesthesia, a jugular venous bulb catheter(16G, manufactured by Arrow International Inc. USA) will be placed in the dominant side. The proper placement of the tip of the catheter in the jugular bulb will be confirmed later by a postoperative lateral skull X-ray. SjvO2 (blood sample will be drawn slowly at a speed of 2ml per minute) will be measured before anesthesia, at extubation, 30, 60, 90, and 120 min after extubation.

Also known as: blood oxygen saturation of jugular vein bulb (SjvO2)
Patients undergoing craniotomy

Surgery types include total or subtotal removal of tumors.For all surgical procedures, general anesthesia will be maintained with isoflurane (0.5-1.0 minimal alveolar concentration (MAC) expired), repeated boluses of fentanyl (1\~2 µg/kg IV), and continuous vecuronium 50~70 IV. All patients will be mechanical ventilated with oxygen. During anesthesia, blood pressure and heart rate will be kept stable, within ±10% of the preoperative levels. Hematocrit (Hct) will be maintained higher than 30%. After surgery, tracheal extubation will be performed when patients regain full muscle strength, breathe spontaneously with acceptable oxygenation and normocapnia.

Also known as: craniotomy under general anesthesia
Patients undergoing craniotomy

After local anesthesia, an intra-arterial pressure line(I.V. catheter and pressure line kit are both manufactured by Smiths Medical International Ltd. USA) will be inserted in radial artery. Sample blood will be drawn from the line before anesthesia, at tracheal extubation, and 30, 60, 90, 120 min after tracheal extubation.

Patients undergoing abdominal surgeryPatients undergoing craniotomy

For all surgical procedures, general anesthesia will be maintained with isoflurane (0.5-1.0 minimal alveolar concentration (MAC) expired), repeated boluses of fentanyl (1\~2 µg/kg IV), and continuous vecuronium 50~70 IV. All patients will be mechanical ventilated with oxygen. During anesthesia, blood pressure and heart rate will be kept stable, within ±10% of the preoperative levels. Hematocrit (Hct) will be maintained higher than 30%. After surgery, tracheal extubation will be performed when patients regain full muscle strength, breathe spontaneously with acceptable oxygenation and normocapnia.

Patients undergoing abdominal surgery

Eligibility Criteria

Age25 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesia (ASA) physical status I or II
  • Scheduled for selective supratentorial tumor removal surgery or major abdominal surgery.

You may not qualify if:

  • Patients with evidence of systemic hypertension, intracranial hypertension, cerebrovascular diseases, other coexisting medical conditions likely to affect cerebral autoregulation.
  • Preoperatively planned delayed tracheal extubation.
  • Pregnant or nursing women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Huashan Hospital

Shanghai, Shanghai Municipality, 200040, China

Location

Related Publications (7)

  • Rasmussen M, Juul N, Christensen SM, Jonsdottir KY, Gyldensted C, Vestergaard-Poulsen P, Cold GE, Ostergaard L. Cerebral blood flow, blood volume, and mean transit time responses to propofol and indomethacin in peritumor and contralateral brain regions: perioperative perfusion-weighted magnetic resonance imaging in patients with brain tumors. Anesthesiology. 2010 Jan;112(1):50-6. doi: 10.1097/ALN.0b013e3181c38bd3.

    PMID: 19952725BACKGROUND
  • Randell T, Niskanen M. Management of physiological variables in neuroanaesthesia: maintaining homeostasis during intracranial surgery. Curr Opin Anaesthesiol. 2006 Oct;19(5):492-7. doi: 10.1097/01.aco.0000245273.92163.8e.

    PMID: 16960480BACKGROUND
  • Clavier N, Schurando P, Raggueneau JL, Payen DM. Continuous jugular bulb venous oxygen saturation validation and variations during intracranial aneurysm surgery. J Crit Care. 1997 Sep;12(3):112-9. doi: 10.1016/s0883-9441(97)90040-x.

    PMID: 9328850BACKGROUND
  • Bruder N, Pellissier D, Grillot P, Gouin F. Cerebral hyperemia during recovery from general anesthesia in neurosurgical patients. Anesth Analg. 2002 Mar;94(3):650-4; table of contents. doi: 10.1097/00000539-200203000-00031.

    PMID: 11867391BACKGROUND
  • Rijbroek A, Boellaard R, Vriens EM, Lammertsma AA, Rauwerda JA. Comparison of transcranial Doppler ultrasonography and positron emission tomography using a three-dimensional template of the middle cerebral artery. Neurol Res. 2009 Feb;31(1):52-9. doi: 10.1179/174313208X325191. Epub 2008 Jul 25.

    PMID: 18662500BACKGROUND
  • Sorond FA, Hollenberg NK, Panych LP, Fisher ND. Brain blood flow and velocity: correlations between magnetic resonance imaging and transcranial Doppler sonography. J Ultrasound Med. 2010 Jul;29(7):1017-22. doi: 10.7863/jum.2010.29.7.1017.

    PMID: 20587424BACKGROUND
  • Macmillan CS, Andrews PJ. Cerebrovenous oxygen saturation monitoring: practical considerations and clinical relevance. Intensive Care Med. 2000 Aug;26(8):1028-36. doi: 10.1007/s001340051315.

    PMID: 11030158BACKGROUND

MeSH Terms

Conditions

Brain NeoplasmsHyperemia

Interventions

Ultrasonography, Doppler, Transcranial

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

EchoencephalographyNeuroradiographyNeuroimagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisRadiographyUltrasonographyUltrasonography, DopplerDiagnostic Techniques, NeurologicalInvestigative Techniques

Limitations and Caveats

The study population was not homogenous according to tumor size and location.

Results Point of Contact

Title
Xiao-Yu Yang
Organization
Huashan Hospital Fudan University

Study Officials

  • Xiao-Yu Yang, Master

    Huashan Hospital

    PRINCIPAL INVESTIGATOR
  • Shou-Jing Zhou, Master

    Huashan Hospital

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 8, 2012

First Posted

July 17, 2012

Study Start

November 1, 2012

Primary Completion

January 1, 2013

Study Completion

January 1, 2013

Last Updated

June 24, 2013

Results First Posted

April 23, 2013

Record last verified: 2013-05

Locations